Suppr超能文献

围手术期疼痛管理中的非甾体类抗炎药。作用机制及最佳使用原理。

Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use.

作者信息

Cashman J, McAnulty G

机构信息

Department of Anaesthesia, St George's Hospital, London, England.

出版信息

Drugs. 1995 Jan;49(1):51-70. doi: 10.2165/00003495-199549010-00005.

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a group of agents with similar actions but diverse chemical structures. Aspirin (acetylsalicylic acid) and sodium salicylate were the first drugs of this type to be used clinically. However, over the past 3 decades there has been a dramatic increase in the number of NSAIDs available for the treatment of postoperative pain. Tissue injury, such as occurs with surgical intervention, is associated with the release of numerous inflammatory mediators including prostaglandins. Prostaglandins derived from the arachidonic acid cascade are implicated in the production of inflammatory pain, and in sensitising nociceptors to the actions of other mediators. They are synthesised from arachidonic acid via the endoperoxide biosynthesis pathway, the initial step of which is catalysed by the enzyme cyclo-oxygenase. Two forms of the cyclo-oxygenase enzyme (COX-1 and COX-2) have been characterised. COX-1 is important in circumstances where prostaglandins have a protective effect such as gastric mucus production and renal blood flow maintenance. NSAIDs inhibit the synthesis of prostaglandins at 1 or more points in the endoperoxide pathway. Three mechanisms of inhibition of the biosynthetic enzymes have been proposed: (i) rapid, reversible competitive inhibition; (ii) irreversible, time-dependent inhibition; and (iii) rapid, reversible noncompetitive (free radical trapping) inhibition. In addition, there is evidence that NSAIDs have a central antinociceptive mechanism of action that augments the peripheral effect. This may involve inhibition of central nervous system prostaglandins or inhibition of excitatory amino acids or bradykinins. There is considerable variability in the pain relief obtained from NSAIDs. Such variability in drug response may be explained in terms of differences between agents with respect to either pharmacodynamic actions or pharmacokinetic parameters or a combination of both. Stereoisomerism, where preparations exist as racemic mixtures and where only 1 enantiomer is active, may also be important. However, chiral inversion from inactive to active enantiomer may occur and may be rapid or slow. NSAIDs have numerous adverse effects. Gastrointestinal disturbances including ulceration are the commonest adverse responses to NSAIDs and carry the greatest risk of death. Also significant are renal impairment and an increased risk of postoperative haemorrhage. Asthma and allergic reactions are uncommon.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

非甾体抗炎药(NSAIDs)是一类作用相似但化学结构各异的药物。阿司匹林(乙酰水杨酸)和水杨酸钠是最早用于临床的这类药物。然而,在过去30年里,可用于治疗术后疼痛的NSAIDs数量急剧增加。组织损伤,如手术干预时发生的损伤,与包括前列腺素在内的多种炎症介质的释放有关。源自花生四烯酸级联反应的前列腺素与炎性疼痛的产生有关,并使伤害感受器对其他介质的作用敏感。它们通过内过氧化物生物合成途径由花生四烯酸合成,该途径的第一步由环氧化酶催化。已鉴定出两种形式的环氧化酶(COX-1和COX-2)。COX-1在前列腺素具有保护作用的情况下很重要,如胃黏液分泌和肾血流量维持。NSAIDs在过氧化物途径的1个或多个点抑制前列腺素的合成。已提出三种抑制生物合成酶的机制:(i)快速、可逆的竞争性抑制;(ii)不可逆、时间依赖性抑制;(iii)快速、可逆的非竞争性(自由基捕获)抑制。此外,有证据表明NSAIDs具有增强外周效应的中枢抗伤害感受作用机制。这可能涉及抑制中枢神经系统前列腺素或抑制兴奋性氨基酸或缓激肽。从NSAIDs获得的疼痛缓解存在相当大的变异性。药物反应的这种变异性可以从药物动力学作用或药代动力学参数或两者结合方面的差异来解释。立体异构现象也可能很重要,即制剂以消旋混合物形式存在,只有1种对映体具有活性。然而,可能会发生无活性对映体向活性对映体的手性转化,且可能快或慢。NSAIDs有许多不良反应。包括溃疡在内的胃肠道紊乱是对NSAIDs最常见的不良反应,且死亡风险最大。肾功能损害以及术后出血风险增加也很显著。哮喘和过敏反应不常见。(摘要截选至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验